Enanta Pharmaceuticals Inc (NASDAQ:ENTA)

42.82
Delayed Data
As of 12:59pm ET
 -0.12 / -0.28%
Today’s Change
38.40
Today|||52-Week Range
67.88
-30.69%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Biotechnology
MARKET CAP
$875.3M

Company Description

Enanta Pharmaceuticals, Inc. operates as a biotechnology company. It engages in the research and development of molecule drugs for the treatment of viral infections and liver diseases. The firm offers the medicine under the brands Mavyret and Viekira Pak. The company was founded by Peter O. Kliem and Gregory L. Verdine in 1995 and is headquartered in Watertown, MA.

Contact Information

Enanta Pharmaceuticals, Inc.
500 Arsenal Street
Watertown Massachusetts 02472
P:(617) 607-0800
Investor Relations:
(617) 744-3848

Employees

Shareholders

Mutual fund holders48.18%
Other institutional46.60%
Individual stakeholders34.65%

Top Executives

Jay R. LulyPresident, Chief Executive Officer & Director
Paul J. MellettSVP, Chief Financial & Administration Officer
Yat Sun OrCSO, Senior Vice President-Research & Development
Nathalie AddaChief Medical Officer & Senior Vice President
Nathaniel S. GardinerSenior Vice President & General Counsel